Pliant Therapeutics Inc (PLRX)

14.18 +0.11  +0.78% NASDAQ Nov 30, 16:00 14.24 +0.06  +0.42% After-Hours: 20:00 USD

Pliant Therapeutics Total Liabilities (Quarterly):

13.68M for Sept. 30, 2021
View 4,000+ financial data types
Browse...
View Full Chart

Total Liabilities (Quarterly) Chart

Export Data
Save Image
Print Image

Historical Total Liabilities (Quarterly) Data

View and export this data going back to 2019. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Sept. 30, 2021 13.68M
June 30, 2021 11.74M
March 31, 2021 11.08M
Dec. 31, 2020 12.46M
   
Sept. 30, 2020 11.98M
June 30, 2020 12.99M
March 31, 2020 10.50M
Dec. 31, 2019 119.50M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

Advertisement

Total Liabilities Definition

Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.

Read full definition.

Total Liabilities (Quarterly) Benchmarks

Jaguar Health Inc 37.70M
Progenity Inc 274.65M
RenovoRx Inc 0.625M

Total Liabilities (Quarterly) Range, Past 5 Years

Minimum 10.50M Mar 2020
Maximum 119.50M Dec 2019
Average 25.49M

Total Liabilities (Quarterly) Related Metrics

Total Assets (Quarterly) 234.12M
Shareholders Equity (Quarterly) 220.44M
Current Ratio 17.69

News

Top Premarket Gainers
MT Newswires 09/07 08:09 ET
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.